Latigo Biotherapeutics is advancing a pipeline of non-opioid pain treatments, with lead candidate LTG-001 showing promising ...
- License and development agreement with Janssen leverages Pipeline’s expertise in precision neuroregeneration and Janssen’s development experience across nervous system disorders SAN DIEGO--(BUSINESS ...
By Bhanvi Satija and Dominique Patton LONDON, July 30 (Reuters) - Sanofi raised its full-year sales forecast on Thursday on ...
The world of Alzheimer's treatments is at an inflection point as more potential drugs make their way out of clinical trials. On the heels of newly FDA-approved drugs Aduhelm (aducanumab) in 2021 and ...
More than 6 million Americans are living with Alzheimer's disease, a staggering number that's expected to double within the next 30 years. But there are signs of optimism in the fight against ...
Kevuru Games’ Zero-Downtime Pipeline fixes 7 common pitfalls. See the framework and get a quote. WASHINGTON D.C., DC, UNITED STATES, July 22, 2026 /EINPresswire.com/ — Kevuru Games has formalized a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results